Hot stocks: Brokerage view on Bajaj Auto, Emcure Pharma, LTIMindtree and Bajaj Finance

CLSA maintains an underperform rating on Bajaj Auto with a target price of Rs 7,000. The recent launch of entry-level motorcycles by Bajaj and Triumph, particularly the Speed T4, is seen as promising. However, caution is warranted due to rising competition in the premium segment, moderated growth in the over-250cc category, and ongoing pressure in […]

Mazagon Dock Shipbuilders shares to trade ex-dividend tomorrow

Shares of defense PSU Mazagon Dock Shipbuilders are in focus today, as the company has set September 19 as the record date for determining shareholder eligibility for dividend payments. Consequently, today is the last opportunity to purchase shares to qualify for the announced dividend of Rs 12.11 per share, which was declared earlier in May […]

Last day to buy for eligibility! Multibagger smallcap stock goes for 1:10 stock split

Nandan Denim, a multibagger small-cap company, is attracting attention today as the board of directors has set September 19 as the record date for its 1:10 stock split. Consequently, today is the last opportunity for investors to purchase shares and qualify for the split. The company had approved the share sub-division earlier in June before […]

Traders shy away from Modi-linked stocks in shift to defensives

A few recent policy reversals highlight the element of uncertainty that investors must grapple with after a decade of certainty, as Modi increasingly leans on coalition partners. That’s led to concerns stocks tied to government policies may continue to trail the broader market.

Asian stocks rise as traders await Fed decision

Japanese shares led regional gains as the yen’s slide on Tuesday boosted the outlook for the nation’s exporters. The dollar bounced in New York following stronger-than-expected retail-sales data. Hong Kong is shut for a holiday, while Chinese stocks listed on mainland markets will resume trading after a break.

Goldman-backed Aragen eyes $150 million as pre-IPO dose; Novo Nordisk keen

Investors including Quadria Capital and Denmark-based pharmaceutical major Novo Nordisk are among those interested in a minority stake and engaged in early discussions, they said. In February, Novo Holdings, the holding company of Novo Nordisk, acquired US-based publicly-listed contract development and manufacturing organisation Catalent for $16.5 billion.